Dynacirc and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Dynacirc (isradipine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Coreg, and have High blood pressure.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Dynacirc. It is created by eHealthMe based on reports of 959 people who have side effects when taking Dynacirc from the FDA, and is updated regularly.

What is Dynacirc?

Dynacirc has active ingredients of isradipine. eHealthMe is studying from 975 Dynacirc users. Check the latest studies of Dynacirc.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,768 drugs and 2,908 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

On Apr, 30, 2026

959 people reported to have side effects when taking Dynacirc.
Among them, 15 people (1.56%) have Hypersensitivity.

Among these 15 people:

How long have people been on Dynacirc when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Dynacirc? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Hypersensitivity when taking Dynacirc? *

What are other drugs people take besides Dynacirc? *

What are other side effects people have besides Hypersensitivity? *

High Blood Pressure: 4 people, 26.67%
Rashes (redness): 4 people, 26.67%
Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 3 people, 20.00%
Dyspnea (difficult or laboured breathing): 3 people, 20.00%
Itching: 3 people, 20.00%
Acute Kidney Failure: 3 people, 20.00%
Swelling Face: 3 people, 20.00%
Sensation Of Foreign Body: 2 people, 13.33%
Hypotension (abnormally low blood pressure): 2 people, 13.33%
Diarrhea: 2 people, 13.33%

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 33.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Pain: 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 6.67%
Oedema Peripheral (superficial swelling): 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
Hepatitis C: 1 person, 6.67%
Gout (uric acid crystals building up in the body): 1 person, 6.67%
Blood Pressure Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dynacirc and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dynacirc:

Dynacirc (975 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Dynacirc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,768 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,908 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on isradipine (the active ingredients of Dynacirc) and Dynacirc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.